edgepedia

All articles A–Z

519,064 articles

Fibrinolytic therapy

Fibrinolytic therapy is drug treatment that dissolves blood clots by converting plasminogen to plasmin, used in heart attack, stroke, and pulmonary embolism, with bleeding as its main risk.

Fibrinopeptide A

Fibrinopeptide A is a 16-residue peptide cleaved from fibrinogen by thrombin during blood coagulation, exposing polymerization sites for clot formation and serving as a clinical marker of thrombin activity.

Fibro-adipose vascular anomaly

Fibro-adipose vascular anomaly (FAVA), a rare ISSVA-provisionally unclassified vascular malformation first described in 2014, causes painful fibrofatty intramuscular lesions with contractures, PIK3CA mutations, and frequent misdiagnosis as venous malformation.

Fibroadenoma

Fibroadenoma, the commonest benign breast tumor, a biphasic epithelial-stromal lesion of reproductive-age women; diagnosed by triple assessment, usually observed, excised if large, growing, or discordant.

Fibroadenosis of breast

Fibroadenosis of breast, also called fibrocystic breast changes or fibrocystic breast disease, is a common benign condition with lumpy breast tissue from fibrosis, cysts, and adenosis; it does not raise breast cancer risk.

Fibrobacter

Fibrobacter, genus Fibrobacterota, gram-negative anaerobic cellulolytic bacteria of mammalian guts; two species, F. succinogenes (rumen) and F. intestinalis; named Montgomery et al. 1988; noncellulosomal cellulase system.

Fibroblast

Fibroblast: connective tissue cell secreting collagen-rich extracellular matrix; also called fibrocytes when quiescent. Term coined by Ziegler 1895; differentiates into contractile myofibroblasts during wound healing; profoundly heterogeneous across organs.

Fibroblast growth factor

Fibroblast growth factors (FGFs), also called heparin-binding growth factors, are a 22-gene family of signaling proteins acting through FGFR tyrosine kinase receptors with heparan sulfate or Klotho cofactors, governing development, wound repair, metabolism, and cancer.

Fibroblast growth factor receptor

Fibroblast growth factor receptors (FGFR1-4) are transmembrane receptor tyrosine kinases for FGF ligands, altered in 5-10% of cancers; targeted by approved inhibitors erdafitinib, pemigatinib, and futibatinib, limited by gatekeeper-mutation resistance and hyperphosphatemia.

Fibroblast growth factor receptor 1

Fibroblast growth factor receptor 1 (FGFR1, CD331, BFGFR) is an 822-amino-acid human receptor tyrosine kinase on chromosome 8 that binds FGFs via IgII-III domains; variants cause Kallmann and Pfeiffer syndromes, and fusions drive 8p11 myeloproliferative syndrome.

Fibroblast growth factor receptor 2

Fibroblast growth factor receptor 2, or FGFR2, is a receptor tyrosine kinase on chromosome 10 that signals for bone and tissue development; activating mutations cause craniosynostosis syndromes and FGFR2 fusions are drug targets in cholangiocarcinoma.

Fibroblast growth factor receptor 3

FGFR3 (fibroblast growth factor receptor 3) is a chromosome 4 receptor tyrosine kinase that limits cartilage-to-bone growth; gain-of-function mutations cause achondroplasia and related skeletal dysplasias, loss-of-function CATSHL, and somatic mutations recur in bladder cancer.

Fibroblastic disorders

Fibroblastic disorders (ICD-11 FB51) are soft-tissue conditions driven by fibroblast or myofibroblast proliferation, including palmar and plantar fibromatosis (Dupuytren, Ledderhose), knuckle pads, fibroblastic rheumatism, and retroperitoneal fibrosis.

Fibroblastic reticular cell tumour

Fibroblastic reticular cell tumour (FRCT), also called cytokeratin-positive interstitial reticulum cell tumor, is a rare malignant stromal neoplasm of lymphoid tissue (ICD-O 9759/3, ICD-11 2B31.7) affecting lymph nodes, spleen, and soft tissue, positive for cytokeratin, SMA, desmin, and CD68.

Fibroblastic rheumatism

Fibroblastic rheumatism (le rhumatisme fibroblastique), ORPHA:477650, is a rare rheumatologic disease first described in 1980, combining sudden symmetric distal polyarthritis with firm skin nodules, sclerodactyly, and fibroblastic dermal proliferation; about 30 cases reported worldwide.

Fibrochondrogenesis

Fibrochondrogenesis (ORPHA:2021, OMIM 228520/614524) is a rare, mostly neonatally lethal short-limb skeletal dysplasia from COL11A1 or COL11A2 mutations affecting type XI collagen, with flat midface, dumbbell long bones, and pinched vertebral bodies.

Fibrodysplasia ossificans progressiva

Fibrodysplasia ossificans progressiva (FOP, myositis ossificans progressiva, stone man disease) is an ultra-rare ACVR1 genetic disorder in which muscle, tendons, and ligaments progressively turn to bone, marked by congenital malformed big toes, flare-ups, and treatments palovarotene, garetosmab, and zilurgisertib.

Fibrolamellar hepatocellular carcinoma

Fibrolamellar hepatocellular carcinoma (FLC, FL-HCC) is a rare liver cancer of adolescents and young adults with healthy livers, defined by the DNAJB1::PRKACA fusion from a chromosome 19 deletion; surgery is the only curative treatment.

Fibroma

Fibroma: a benign tumor of fibrous connective tissue, also called fibrous tumor; includes plantar, non-ossifying, oral, ovarian, and skin types; malignant counterpart is fibrosarcoma.

Fibromatosis of breast

Fibromatosis of the breast, also called mammary or desmoid-type fibromatosis, is a rare, locally aggressive, non-metastasizing fibroblastic breast tumor with Wnt/beta-catenin activation, now often managed by active surveillance.

Fibromuscular dysplasia

Fibromuscular dysplasia (FMD) is an idiopathic, non-inflammatory, non-atherosclerotic arteriopathy of medium arteries, mainly renal and cervicocranial, affecting women, causing stenosis, aneurysm, dissection, and hypertension.

Fibromyalgia

Fibromyalgia, also called fibromyalgia syndrome, is a chronic disorder of widespread pain, fatigue, and sleep problems, diagnosed clinically with no biomarker. It affects about 1.5–2% of people, mostly women; exercise is first-line, drugs give only small benefits.

Fibronectin

Fibronectin: dimeric adhesive glycoprotein of blood, cell surfaces, and extracellular matrix; RGD motif, α5β1 integrin receptor, stretch-driven fibrillogenesis, wound healing, and bacterial FnBP target.

Fibronectin glomerulopathy

Fibronectin glomerulopathy (GFND, glomerulopathy with fibronectin deposits): rare autosomal dominant kidney disease from FN1 mutations, with fibronectin deposits in glomeruli, proteinuria, hematuria, hypertension, and end-stage renal disease in 15-20 years.

Fibropapillomatosis

Fibropapillomatosis (FP), sea turtle fibropapilloma disease linked to Chelonid alphaherpesvirus 5 (ChHV5), causing cutaneous and internal tumors, mainly in green turtles (Chelonia mydas), first described 1938, panzootic since the 1990s.

Fibropolycystic liver disease

Fibropolycystic liver disease (ductal plate malformation, fibrocystic liver disease) is a spectrum of heritable ciliopathy disorders of intrahepatic bile ducts, including congenital hepatic fibrosis, Caroli disease, biliary hamartomas, and polycystic liver disease, causing portal hypertension, cholangitis, and rarely cholangiocarcinoma.

Fibrosarcoma

Fibrosarcoma is a rare malignant tumor of fibroblastic origin arising in deep soft tissue and bone, spanning an aggressive adult form and an infantile form with excellent survival.

Fibrosis

Fibrosis, or fibrotic scarring, is the excessive buildup of scar tissue in organs such as the lung, liver, heart, and kidney after chronic injury, impairing function.

Fibrosis of spleen

Fibrosis of spleen (fibrotic spleen, ICD-11 3B81.9) is excess fibrous connective tissue causing partial or complete splenic degradation, following trauma, toxicity, inflammation, infarction, or neoplasia; confirmed by imaging and elastography.

Fibrosis-neurodegeneration-cerebral angiomatosis syndrome

FINCA syndrome (fibrosis, neurodegeneration, cerebral angiomatosis; OMIM 618278, ORPHA:621758) is a rare autosomal recessive NHLRC2-related infantile multisystem disorder with interstitial lung fibrosis, neurodevelopmental delay, seizures, recurrent infections, and macrocytic anemia.